Alerts will be sent to your verified email
Verify Email
ANG
|
ANG Lifesciences
|
Vilin Bio Med
|
Guj. Terce Lab
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.51 % | 3.34 % | -8.22 % |
|
5yr average Equity Multiplier
|
3.24 | 1.75 | 3.01 |
|
5yr Average Asset Turnover Ratio
|
0.88 | 0.81 | 1.65 |
|
5yr Avg Net Profit Margin
|
1.44 % | 2.69 % | -2.03 % |
|
Price to Book
|
0.61 | 0.0 | 6.18 |
|
P/E
|
0.0 | 175.15 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
57.8 Days | 147.94 Days | -31.87 Days |
|
Inventory Days
|
76.41 Days | 58.04 Days | 41.53 Days |
|
Days Receivable
|
195.39 Days | 130.3 Days | 51.92 Days |
|
Days Payable
|
179.71 Days | 44.85 Days | 99.88 Days |
|
5yr Average Interest Coverage Ratio
|
2.65 | 1.79 | -0.27 |
|
5yr Avg ROCE
|
22.81 % | 9.64 % | -3.24 % |
|
5yr Avg Operating Profit Margin
|
10.92 % | 9.07 % | -1.67 % |
|
5 yr average Debt to Equity
|
0.87 | 0.57 | 0.65 |
|
5yr CAGR Net Profit
|
n/a | 0.0 | -3.04 % |
|
5yr Average Return on Assets
|
3.23 % | 1.96 % | -2.45 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
70.6 % | 63.89 % | 37.03 % |
|
Share Pledged by Promoters
|
44.88 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-0.54 % | -0.63 % | 0.81 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
ANG Lifesciences
|
Vilin Bio Med
|
Guj. Terce Lab
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|